Leerink Swann Downgrades Impax Laboratories (IPXL) to Market Perform
Tweet Send to a Friend
Leerink Swann downgraded Impax Laboratories (NASDAQ: IPXL) from Outperform to Market Perform with a price target of $16.00 (from $23.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
